Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer (original) (raw)

Abstract

Purpose. Nuclear expression of Y box-binding protein (YB-1), a member of the DNA-binding protein family, was recently reported to have a much higher concentration in cisplatin-resistant cancer cell lines than in their drug-sensitive parental counterparts, suggesting the ability to induce cisplatin resistance. Ovarian cancer has been generally treated with cisplatin-based chemotherapy and often recurs due to acquired cisplatin resistance. The aim of our study is to elucidate the association between nuclear YB-1 and cisplatin resistance in human ovarian cancer using cultured cell lines and surgical specimens.

Methods. Intracellular YB-1 localization was examined by Western blot analysis for both cisplatin sensitive and resistant human ovarian cancer cell lines. Moreover, 35 pairs of surgical specimens derived from primary and matched recurrent ovarian cancers of the same patient were evaluated for their nuclear YB-1 expression by immunohistochemical staining.

Results. Western blot analysis for nuclear and cytoplasmic extracts indicated that cisplatin-resistant cells showed much higher nuclear YB-1 expression than sensitive parental cells. Immunohistochemical analysis showed that ten paired cases turned from negative nuclear YB-1 in primary lesions to positive nuclear YB-1 in recurrent lesions, whereas only two paired cases showed a reverse turn from positive to negative.

Conclusions. The expression of YB-1 in the nucleus seems to be associated with acquired cisplatin resistance in ovarian cancers. Nuclear YB-1 might be a useful predictive marker indicating cisplatin sensitivity and/or a target molecule to treat recurring ovarian cancers by cisplatin-based second-line chemotherapy.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan, , , , ,
    Hideaki Yahata, Hiroaki Kobayashi, Satoshi Amada, Toshio Hirakawa & Hitoo Nakano
  2. Department of Obstetrics and Gynecology, Kurume University, Kurume, Japan, , , , ,
    Toshiharu Kamura
  3. Department of Molecular Biology, University of Occupational and Environmental Health, Kitakyushu, Japan, , , , ,
    Kimitoshi Kohno
  4. Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, , , , ,
    Michihiko Kuwano

Authors

  1. Hideaki Yahata
    You can also search for this author inPubMed Google Scholar
  2. Hiroaki Kobayashi
    You can also search for this author inPubMed Google Scholar
  3. Toshiharu Kamura
    You can also search for this author inPubMed Google Scholar
  4. Satoshi Amada
    You can also search for this author inPubMed Google Scholar
  5. Toshio Hirakawa
    You can also search for this author inPubMed Google Scholar
  6. Kimitoshi Kohno
    You can also search for this author inPubMed Google Scholar
  7. Michihiko Kuwano
    You can also search for this author inPubMed Google Scholar
  8. Hitoo Nakano
    You can also search for this author inPubMed Google Scholar

Additional information

Electronic Publication

Rights and permissions

About this article

Cite this article

Yahata, H., Kobayashi, H., Kamura, T. et al. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.J Cancer Res Clin Oncol 128, 621–626 (2002). https://doi.org/10.1007/s00432-002-0386-6

Download citation